Progyny Inc (PGNY)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Operating income (ttm) US$ in thousands 67,455 65,468 71,199 65,696 62,184 51,690 44,756 38,410 23,341 19,847 17,657 20,475 32,340 33,689 29,452 16,724 8,348 8,331 6,572
Revenue (ttm) US$ in thousands 1,167,818 1,140,069 1,135,369 1,111,361 1,091,902 1,036,101 959,749 874,714 787,727 700,482 617,337 551,196 501,082 473,730 450,213 385,920 344,979 309,953 272,210
Operating profit margin 5.78% 5.74% 6.27% 5.91% 5.70% 4.99% 4.66% 4.39% 2.96% 2.83% 2.86% 3.71% 6.45% 7.11% 6.54% 4.33% 2.42% 2.69% 2.41%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $67,455K ÷ $1,167,818K
= 5.78%

The operating profit margin of Progyny Inc has shown fluctuations over the periods from June 30, 2020, to December 31, 2024. Starting at 2.41% in June 2020, the margin increased to 7.11% by September 2021, indicating improvement in operational efficiency and profitability. However, there was a slight decline in the margin to 2.86% by June 2022, which continued to decrease to 2.83% by September 2022.

The operating profit margin then experienced a significant rise to 6.27% by June 2024, demonstrating a recovery in profitability for Progyny Inc. This positive trend was followed by a relatively stable margin around 5.70% to 5.91% from December 2023 to March 2024. Finally, the margin settled at 5.78% by December 31, 2024.

Overall, the operating profit margin of Progyny Inc indicates varying levels of profitability over the observed periods. Despite fluctuations, the company managed to improve its operational efficiency and generate stronger profits, showing resilience and potential for sustainable growth in the future.


Peer comparison

Dec 31, 2024

Company name
Symbol
Operating profit margin
Progyny Inc
PGNY
5.78%
DaVita HealthCare Partners Inc
DVA
16.31%
Sotera Health Co
SHC
26.37%